Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Data from the dosing conditions trial (NCT01572753) [15] confirmed the above model-derived conclusions regarding bioavailability: with repeated dosing, the exposure variability was reduced, and the 90% exposure range reduced from approximately 20-fold after the first dose to around five-fold after the tenth dose (Fig
Namoju RC, Khan S, Patel RS et al (2014) Pre-pubertal exposure of cytarabine-induced testicular atrophy, impaired spermatogenesis and germ cell DNA damage in SD rats
SYNC Life evaluates health through advanced testing of over 100 biomarkers and creates personalized wellness plans that address root causes of issues like low energy, poor gut health, weight gain, and stress, with ongoing progress tracking and clinical guidance
Always consult your healthcare provider about potential risks
